Behavioural effects of the newer antiepileptic drugs: an update
Data up to Jan 2025
Total Citations Per Year
Abstract
References (64)
A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
1999 • 1,056 citations
Severe persistent visual field constriction associated with vigabatrin
1997 • 453 citations
Gabapentin in bipolar disorder: a placebo‐controlled trial of adjunctive therapy1
2000 • 318 citations
Topiramate and Psychiatric Adverse Events in Patients with Epilepsy
2003 • 248 citations
Randomised, Placebo‐Controlled Study of Vigabatrin as First‐Line Treatment of Infantile Spasms
1999 • 231 citations
Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients
2000 • 219 citations
Review of the Use of Topiramate for Treatment of Bipolar Disorders
2002 • 217 citations
Use of topiramate, a new anti-epileptic as a mood stabilizer
1998 • 199 citations
Oxcarbazepine in Affective and Schizoaffective Disorders
2001 • 199 citations
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug
2001 • 189 citations
Vigabatrin and psychosis.
1991 • 182 citations
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials
2003 • 178 citations
Topiramate versus Bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single‐blind study
2002 • 170 citations
Levetiracetam Psychosis in Children with Epilepsy
2001 • 156 citations
Carbamazepine Toxicity with Lamotrigine: Pharmacokinetic or Pharmacodynamic Interaction?
1998 • 156 citations
Safety Profile of Levetiracetam
2001 • 132 citations
Gabapentin Toxicity in Children Manifesting as Behavioral Changes
1995 • 126 citations
Psychiatric symptoms after therapy with new antiepileptic drugs: Psychopathological and seizure related variables
2000 • 126 citations
Tiagabine: The Safety Landscape
1995 • 122 citations
Tiagabine
1998 • 117 citations
Psychiatric adverse events during vigabatrin therapy
1999 • 112 citations
Aggressive Behaviour in Intellectually Challenged Patients with Epilepsy Treated with Lamotrigine
1998 • 106 citations
Effects of Mianserin on Negative Symptoms in Schizophrenia
1990 • 106 citations
Tiagabine-induced absence status in idiopathic generalized epilepsy
1999 • 105 citations
Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders
2002 • 100 citations
Acute psychotic symptoms induced by topiramate
1999 • 99 citations
The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania
1994 • 98 citations
Behavioural Effects of the New Anticonvulsants
2001 • 97 citations
Childhood epilepsy in relation to mental handicap and behavioural disorders
2002 • 94 citations
Efficacy of gabapentin therapy in children with refractory partial seizures
1996 • 94 citations
Tiagabine Appears Not to Be Efficacious in the Treatment of Acute Mania
1999 • 93 citations
Tiagabine
1998 • 92 citations
Tiagabine and non-convulsive status epilepticus
1996 • 86 citations
Psychotic and severe behavioural reactions with vigabatrin: a review
2009 • 83 citations
Nonconvulsive Status Epilepticus in Two Patients Receiving Tiagabine Treatment
1998 • 81 citations
A Pilot Study of Topiramate as Monotherapy in the Treatment of Acute Mania
2001 • 75 citations
An audit of topiramate use in a general neurology clinic
1998 • 75 citations
Vigabatrin and behaviour disorders: a retrospective survey
1996 • 74 citations
Psychotic episodes during Zonisamide treatment
2000 • 73 citations
Neuropsychological effects of tiagabine, a potential new antiepileptic drug
1994 • 73 citations
Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic
1999 • 72 citations
Felbamate in Epilepsy Therapy
1999 • 68 citations
Cognitive and Behavioral Effects of Epilepsy Treatment
2001 • 59 citations
Lamotrigine in the treatment of bipolar depression
1999 • 58 citations
Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs
1996 • 55 citations
Felbamate monotherapy has stimulant-like effects in patients with epilepsy
1996 • 54 citations
Felbamate Monotherapy: Implications for Antiepileptic Drug Development
1995 • 44 citations
Anticonvulsant-Induced Psychiatric Disorders
1996 • 41 citations
Long‐Term Safety of Tiagabine
2001 • 39 citations
Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability.
1998 • 37 citations
Acute psychological disorders in patients with epilepsy: a nation-wide study
1996 • 35 citations
Vigabatrin and behaviour disturbances
1990 • 34 citations
Zonisamide and psychosis
1997 • 33 citations
Cognitive and behavioural assessments in clinical trials: what type of measure?
2001 • 31 citations
Treatment of acute mania with topiramate in hospitalized patients
2002 • 29 citations
Occurrence of Psychosis in Patients with Epilepsy Randomized to Tiagabine or Placebo Treatment
2002 • 29 citations
The Use of Topiramate in Mood Stabilization
2002 • 21 citations
Felbamate as Add-On Therapy
1996 • 20 citations
Vigabatrin in Childhood Epilepsy: Comparable Efficacy for Generalized and Partial Seizures
1996 • 17 citations
Confusion and dysphoria with low‐dose topiramate in a patient with bipolar disorder
2001 • 16 citations
Secondary Mania Associated With the Use of Felbamate
1995 • 8 citations
Topiramat - ein wirksames neues Antiepileptikum
1997 • 4 citations
Oxcarbazepine in Acute Mania
1985 • 3 citations
Topiramat – ein wirksames neues Antiepileptikum Eine offene prospektive Studie
1997 • 2 citations